Christian Kettel Thomsen: The inflation job is basically done in Denmark after a series of unprecedented shocks led to ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

"Farmland values increased at a slower rate, yet 5.5 per cent growth in six months is still a very strong number," said J.P.

Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

The plaintiffs allege that the shortage of Lilly’s drugs isn’t actually over, and that the agency’s decision deprives ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

Shares of WW International Inc., known as WeightWatchers, soared 18% Tuesday, after the weight-management company announced the addition of compounded GLP-1 obesity treatments to its offering. The new ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.